by Eric Christianson | Nov 21, 2021 | Clinical Guideline Updates For Pharmacists
Restless Legs Syndrome (RLS) can be a very difficult diagnosis to manage for some patients. Insomnia, pain and significant discomfort can result on account of this disease. Here are a few of my favorite clinical pearls and with a critical update in the RLS guidelines....
by Eric Christianson | Nov 10, 2021 | Clinical Guideline Updates For Pharmacists
Chemotherapy-induced nausea and vomiting (CINV) is one of the most common side effects in patients getting treated for cancer. Prevention for CINV is important to improve quality of life and treatment outcomes. Acute CINV is from the chemotherapeutic agents producing...
by Eric Christianson | Sep 5, 2021 | Clinical Guideline Updates For Pharmacists
In this article, we provide the latest acne treatment guidelines as well as clinical pearls of the most commonly used agents. Acne is a very common disease that plagues teens and young adults. Acne can persist into later adulthood, but the incidence is far less...
by Eric Christianson | Aug 15, 2021 | Clinical Guideline Updates For Pharmacists
Treatment for patients hospitalized with COVID-19 is continuously evolving. Some medications have proven beneficial over the past year, while others have fallen out of favor. Here we review the most recent guidelines as of August 2021. In short, it is...
by Eric Christianson | Aug 11, 2021 | Clinical Guideline Updates For Pharmacists
Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside of hospitals, (less than 48 hours from hospital admission). Patients will typically present with symptoms including fever, chills, chest pain, cough, sputum production, and dyspnea. Objective...
by Eric Christianson | Mar 10, 2021 | Clinical Guideline Updates For Pharmacists
There are a few important heart failure guideline updates in the works to the American College of Cardiology’s Heart Failure Guidelines, last published in 2013. Prior to the full guideline release, the organization recently printed their updated Expert Consensus...
